Back
Brainstorm Cell Therapeutics Stock Price Chart
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here
Sell
15
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.38
Seasonality Move:
13.57%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing selling pressure, which indicates risk of future bearish movement.
Brainstorm Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.47 | Sell |
| 20-day SMA: | 0.53 | Sell |
| 50-day SMA: | 0.48 | Sell |
| 200-day SMA: | 0.6 | Sell |
| 8-day EMA: | 0.45 | Sell |
| 20-day EMA: | 0.5 | Sell |
| 50-day EMA: | 0.48 | Sell |
| 200-day EMA: | 0.76 | Sell |
Brainstorm Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 37.02 | Sell |
| Chaikin Money Flow: | -303428 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.46 - 0.66) | Sell |
| Bollinger Bands (100): | (0.25 - 0.53) | Sell |
Brainstorm Cell Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Brainstorm Cell Therapeutics Stock
Is Brainstorm Cell Therapeutics Stock a Buy?
- Brainstorm Cell Therapeutics share price is 0.38 while BCLI 8-day simple moving average is 0.47, which is a Sell signal.
- The stock price of BCLI is 0.38 while Brainstorm Cell Therapeutics 20-day SMA is 0.53, which makes it a Sell.
- Brainstorm Cell Therapeutics 50-day simple moving average is 0.48 while BCLI share price is 0.38, making it a Sell technically.
- BCLI stock price is 0.38 and Brainstorm Cell Therapeutics 200-day simple moving average is 0.60, creating a Sell signal.
BCLI Technical Analysis vs Fundamental Analysis
Sell
15
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy or a Sell?
-
Brainstorm Cell Therapeutics stock is rated a Sell
The current Brainstorm Cell Therapeutics [BCLI] share price is $0.38. The Score for BCLI is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Brainstorm Cell Therapeutics Stock Info
Market Cap:
25.97M
Price in USD:
0.38
Share Volume:
539.43K
Brainstorm Cell Therapeutics 52-Week Range
52-Week High:
3.34
52-Week Low:
0.13
Sell
15
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Brainstorm Cell Therapeutics Share Price Forecast
-
What is the Brainstorm Cell Therapeutics stock price today?
The Brainstorm Cell Therapeutics stock price is 0.38 USD today. -
Will BCLI stock go up or go down?
Brainstorm Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Brainstorm Cell Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics is overvalued.
Is Brainstorm Cell Therapeutics Stock a Buy?
- Brainstorm Cell Therapeutics share price is 0.38 while BCLI 8-day exponential moving average is 0.45, which is a Sell signal.
- The stock price of BCLI is 0.38 while Brainstorm Cell Therapeutics 20-day EMA is 0.50, which makes it a Sell.
- Brainstorm Cell Therapeutics 50-day exponential moving average is 0.48 while BCLI share price is 0.38, making it a Sell technically.
- BCLI stock price is 0.38 and Brainstorm Cell Therapeutics 200-day simple moving average is 0.76, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics
Is Brainstorm Cell Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Brainstorm Cell Therapeutics
Should I short Brainstorm Cell Therapeutics stock?
- BCLI Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Brainstorm Cell Therapeutics is a Sell
- Brainstorm Cell Therapeutics Relative Strength Index (RSI) is 37.02, which suggest Brainstorm Cell Therapeutics is oversold
- The Bollinger Bands (25) for Brainstorm Cell Therapeutics is (0.46 - 0.66), which suggest Brainstorm Cell Therapeutics is a Sell
- The Bollinger Bands (100) for Brainstorm Cell Therapeutics is (0.25 - 0.53), which suggest Brainstorm Cell Therapeutics is a Sell
* Brainstorm Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.